Increased rather than decreased incidence of giant-cell arteritis during the COVID-19 pandemic.

Lecler, Augustin; Villeneuve, Delphine; Vignal, Catherine; Sené, Thomas

Lecler, Augustin; Villeneuve, Delphine; Vignal, Catherine; Sené, Thomas.

Lecler A; Neuroradiology, The Fondation Adolphe de Rothschild Hospital, Paris, France alecler@for.paris.
Villeneuve D; Internal Medicine, The Fondation Adolphe de Rothschild Hospital, Paris, France.
Vignal C; Ophthalmology, The Fondation Adolphe de Rothschild Hospital, Paris, France.
Sené T; Internal Medicine, The Fondation Adolphe de Rothschild Hospital, Paris, France.

Ann Rheum Dis ; 80(6): e89, 2021 06.

Article in English | MEDLINE | ID: covidwho-1909673

Subject(s)

COVID-19; Giant Cell Arteritis; Giant Cell Arteritis/epidemiology; Glucocorticoids; Humans; Incidence; Pandemics

Keywords

giant cell arteritis; glucocorticoids; health services research

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Giant Cell Arteritis / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2021 Document Type: Article Affiliation country: Annrheumdis-2020-218343

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google